IVDR differs in a number of respects from the current EU directive on in vitro diagnostic medical devices. The most significant changes in the proposed specification include:
1. Expand the product range;
2. Reclassification of devices;
3. Determine the "compliance principal";
4, improve the degree of participation of announcement institutions;
5. Implementation of unique device identification;
6. Stricter requirements on technical documentation and clinical evidence;
7, the announcement of the body's review is more stringent;
8. There is no "not subject to new regulations" rule.